secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001534969-22-000067
Event type: earnings
Sentiment:  negative
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q1 net loss $12.2M; revenue $38k; PreTRM orders rise
---------------------------------------------------------------------

- Revenue of $38k in Q1 2022 vs $13k in Q1 2021; still minimal.
- Net loss widened to $12.2M from $6.4M; operating expenses $12.3M vs $6.0M.
- Cash and securities total $129.9M as of March 31, 2022.
- Simplified PreTRM ordering process; order trends improving into Q2.
- Preeclampsia biomarker validation expected mid-2022; PRIME study on track for 2023 interim readout.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000067/0001534969-22-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000067/sera-20220510.htm
  HTML page:      https://secwatch.observer/filing/0001534969-22-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer